Skip to main content
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2005 Dec;1(1):23–25. doi: 10.1007/BF03160901

Foxy methoxy: A new drug of abuse

Susan C Smolinske 1,, Rahul Rastogi 2, Stephen Schenkel 3
PMCID: PMC3550011

Abstract

Introduction

In 1999, a new synthetic tryptamine, 5-MeO-DIPT, became known as a street drug, with the street name of “Foxy” or “Foxy Methoxy”. By February 2003, the DEA reported law enforcement seizures and/or reports of abuse in 12 states. We report a case along with an analysis of poison center data on this new drug of abuse.

Case report

A 19-year-old male was brought to the emergency department following ingestion of a larger than his usual dose of Foxy. Upon arrival, he had hallucinations, hypertension, tachycardia, mydriasis, and catalepsy. Symptoms resolved within two hours after administration of lorazepam and he recovered uneventfully.

Discussion

The AAPCC TESS database contained 41 exposures to “Foxy” between April, 2002 and June, 2003; 26 had moderate or major effects, indicating this drug has significant toxic potential. Given the expanding use of this and other club drugs, the spectrum of toxicity from this new agent will continue to be elucidated.

Keywords: tryptamine, serotonin, hallucinogen, catalepsy, poisoning

Full Text

The Full Text of this article is available as a PDF (117.1 KB).

Footnotes

Presented in part as The 2003 North American Congress of Clinical Toxicology Annual meeting, September 4–9, 2003, Chicago, Illinois.

References

  • 1.DEA Intelligence Division Trippin? on Tryptamines: The Emergence of Foxy and AMT as Drugs of Abuse. Microgram Bulletin. 2002;35:264–268. [Google Scholar]
  • 2.Direct NIC [homepage on the Internet], [under construction; cited 1/5/04]. Available from: http://www.edtchemical.com/5-MeO-DIPT.htm.
  • 3.Drug Enforcement Administration Schedules of Controlled Substances:Temporary Placement of Alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine Into Schedule I. Federal Register. 2003;68:4127–4130. [PubMed] [Google Scholar]
  • 4.Shulgin AT, Carter MF. N,N-Diisopropyltryptamine (DIPT) and 5-Methoxy-N,N-Diisopropyltryptamine (5-MeO-DIPT. Two Orally Active Tryptamine Analogs with CNS Activity. Communications in Psychopharmacology. 1980;4:363–369. [PubMed] [Google Scholar]
  • 5.Shulgin A, Shulgin A. PIHKAL: A Chemical Love Story. Berkeley: Transform Press; 1991. [Google Scholar]
  • 6.Long H, Nelson LS, Hoffman RS. Alpha-methyltryptamine: Revisited via easy internet access. Vet Human Toxicol. 2003;45:149–149. [PubMed] [Google Scholar]
  • 7.Meatherall R, Sharma P. Foxy, a designer tryptamine hallucinogen. J Anal Toxicol. 2003;27:313–317. doi: 10.1093/jat/27.5.313. [DOI] [PubMed] [Google Scholar]
  • 8.Olson KR. Phencyclidine. In: Olson KR, editor. Poisoning and drug overdose. 3rd ed. Stamford: Appleton & Lange; 1999. pp. 254–255. [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES